Company / Capital Returned to Shareholders
Catalyst Pharmaceuticals Partners, Inc. Capital Returned to Shareholders History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$25.3M
FY2025
5-year range
$0 / $25.3M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#33 of 52
Health Care
What the data says
At $25M, Catalyst Pharmaceuticals Partners, Inc.'s capital returned to shareholders ranks #33 of 52 in the Health Care sector. Improved from $0 to $25M over the past 2 years.
Based on SEC 10-K filings.
$25M in FY2025 with a 3-year CAGR of +54.2%.
Improved from $0 to $25M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- +54.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#33 of 52 in Health CareTop 63% of 52This company $25.3M Sector average $1.3B
▼
-98.1% below sector average
Key checks
Key Insights
- 3-year CAGR of +54.2%, indicating consistent growth.
- Ranks #33 out of 52 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.3M | - |
| FY2024 | $0 | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $6.9M | -42.9% |
| FY2021 | $12.1M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026